These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37533945)
1. Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis-prevalence and risk factors. Siddiqui MTU; Fareed G; Khan MR; Riaz A; Hamid SS Ecancermedicalscience; 2023; 17():1581. PubMed ID: 37533945 [TBL] [Abstract][Full Text] [Related]
2. Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739 [TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study. Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175 [TBL] [Abstract][Full Text] [Related]
4. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients. Benevento F; Pecorelli A; Stefanescu H; Sparchez Z; Vukotic R; Pettinari I; Grigoras CA; Tovoli F; Ravaioli F; Stefanini B; Andreone P; Piscaglia F J Hepatocell Carcinoma; 2023; 10():473-482. PubMed ID: 37007210 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma. Burciu C; Șirli R; Bende F; Fofiu R; Popescu A; Sporea I; Ghiuchici AM; Miuțescu B; Dănilă M Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626300 [TBL] [Abstract][Full Text] [Related]
6. Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level. Carr BI; Guerra V; Ince V; Isik B; Yilmaz S Liver Res; 2023 Sep; 7(3):256-262. PubMed ID: 37854945 [TBL] [Abstract][Full Text] [Related]
7. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. Pan J; Wang L; Gao F; An Y; Yin Y; Guo X; Nery FG; Yoshida EM; Qi X Eur J Intern Med; 2022 Oct; 104():21-32. PubMed ID: 35688747 [TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219 [TBL] [Abstract][Full Text] [Related]
10. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Connolly GC; Chen R; Hyrien O; Mantry P; Bozorgzadeh A; Abt P; Khorana AA Thromb Res; 2008; 122(3):299-306. PubMed ID: 18045666 [TBL] [Abstract][Full Text] [Related]
12. The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma. Umar NK; Badshah MB; Sandrasegaran K; Ghabril M; Agarwal S; Tann M; Lacerda M; Kwo PY Dig Dis Sci; 2015 Jul; 60(7):2196-200. PubMed ID: 25777258 [TBL] [Abstract][Full Text] [Related]
13. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644 [TBL] [Abstract][Full Text] [Related]
14. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. Lertpipopmetha K; Auewarakul CU BMC Gastroenterol; 2011 Jun; 11():66. PubMed ID: 21658275 [TBL] [Abstract][Full Text] [Related]
15. Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. Zanetto A; Senzolo M; Vitale A; Cillo U; Radu C; Sartorello F; Spiezia L; Campello E; Rodriguez-Castro K; Ferrarese A; Farinati F; Burra P; Simioni P Dig Liver Dis; 2017 Apr; 49(4):440-445. PubMed ID: 28109767 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study. Chen Z; Ran T; Cao H; Xu F; Zhou ZH; He S Front Med (Lausanne); 2021; 8():685944. PubMed ID: 34262917 [No Abstract] [Full Text] [Related]
17. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients. Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181 [TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients. Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319 [TBL] [Abstract][Full Text] [Related]
19. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors]. Lin GS; Xu Q; Zhao SY; Zhang YX Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429 [No Abstract] [Full Text] [Related]
20. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis. Carr BI; Guerra V Dig Dis Sci; 2016 Mar; 61(3):937-47. PubMed ID: 26576554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]